TLI Quarterly — Spring 2020

This edition contains the following: First FDA-Approved NASH Drug Expected in 2020: Quick Facts to Know The Tussle Between Resection and Liver Transplantation in the Treatment of HCC “What advice should I give my patients with cirrhosis regarding COVID-19?” Hepatitis B Vaccination: Who Needs It and Which Options are...

Read More

TLI Quarterly — Spring 2019

This edition contains the following: Living Donor Liver Transplantation An Update on Nonalcoholic Steatohepatitis (NASH) from the International Liver Congress Does direct-acting antiviral exposure affect hepatocellular carcinoma recurrence in patients with HCV cirrhosis? Any News on Hepatitis B Cure?

Read More

TLI Quarterly — Fall 2018

This edition contains the following: A New First-Line Oral Treatment for Advanced Hepatocellular Carcinoma Comprehensive, Cutting-Edge Care at The Texas Liver Tumor Center An Update on the Management of Severe Thrombocytopenia in Patients With Cirrhosis

Read More

TLI Quarterly — Spring 2018

This edition contains the following: Autoimmune Hepatitis: Current And Future Treatment Options Cholangiocarcinoma: Diagnosis And Management Is Green Tea Good For Your Health? What Noninvasive Imaging Techniques Can Measure Liver Steatosis? Is Liver Fibrosis Reversible?

Read More

TLI Quarterly — Fall 2016

This edition contains the following: How Much Alcohol Can I Safely Drink? Does Liver Disease Hurt? Does Replacing Animal Protein With Plant Protein Help People Live Longer? Primary Biliary Cholangitis Living Liver Donation Can Save Lives Otherwise Lost On The Waitlist

Read More